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Somatostatin (33-14) is known as an antigrowth 
factor for a variety of cell types, including gastroin- 
testinal mucosa, exocrine pancreas, lymphocytes, 
and some tumors. We have recently identified and 
biochemically characterized SS-14-binding protein on 
rat liver plasma membranes (S. E. Raper, P. C. Koth- 
ary, and J. DelValle, Gastroenterology 96: A408, 
1989; P. C. Kothary et al., Digestion 46(Suppl 1): 58, 
1990). We hypothesized that SS-14 may affect liver 
growth as well and investigated cellular mechanisms of 
this phenomenon focusing on the second messenger 
CAMP. Freshly isolated, rat hepatocytes were plated 
on tissue culture dishes coated with Matrigel (laminin, 
heparan sulfate, and type IV collagen). The medium 
was not supplemented with serum or hormones. Either 
dibutyryl-CAMP (1 mM) or isobutylmethylxanthine 
(IBMX, 0.1 mM) was added in the presence or absence 
of SS- 14 (10 nM). DNA synthesis was estimated by 
the rate of [‘Hlthymidine incorporation into DNA and 
by the labeling index (an autoradiographic measure- 
ment of the number of labeled nuclei). SS-14 signifi- 
cantly inhibited both rSH]thymidine incorporation and 
labeling index of rat hepatocytes stimulated by dibu- 
tyryl-CAMP or IBMX. SS- 14 also inhibited intracellu- 
lar CAMP accumulation stimulated by IBMX. We con- 
clude that SS-14 exerts at least part of its antiprolifer- 
ative effects via the adenylate cyclase system. Further 
study using other signal transduction systems may 
yield more information about mechanisms of hepato- 
cyte growth. 0 1991 Academic Press, Inc. 
cell types such as gastrointestinal mucosa [2], exocrine 
pancreas [3], lymphocytes [4], and some tumors [5, 61. 
Its long-acting analogue (SMS 201-995) has been tried 
in the treatment of gut endocrine tumors with some re- 
sponse [7]. We have recently identified and biochemi- 
cally characterized an SS-14 binding protein on rat liver 
plasma membranes [8, 91. The presence of SS-14 bind- 
ing protein in the liver has also been confirmed by stud- 
ies demonstrating hepatic uptake of intraportally in- 
jected ‘251-[Tyr11]-SS-14 in a manner partially blocked 
by excess unlabeled SS-14 [lo]. These results led us to 
hypothesize that SS-14 may affect liver growth as well. 
There have been several reports documenting the inhibi- 
tory effects of SS-14 on liver growth [ll, 121. However, 
little is known about the cellular mechanisms of this 
antiproliferative effect. 
In previous studies using other cell types, SS-14 has 
been shown to inhibit various cellular events by atten- 
uating the production of cellular cyclic AMP (CAMP), 
an effect that seems to be mediated via pertussis toxin- 
sensitive inhibitory guanine nucleotide-binding proteins 
[13, 141. A number of physiological findings, using 
CAMP analogues such as dibutyryl-CAMP (db-CAMP), 
suggests that attenuation of CAMP production is not 
sufficient to serve as the only signal for eliciting this 
kind of inhibition [15, 161. Using primary cultures of 
adult rat hepatocytes, we investigated the cellular mech- 
anisms of the antiproliferative effect of SS-14 focusing 
on the adenylate cyclase system. 
INTRODUCTION Materials 
Somatostatin (SS-14) is a tetradecapeptide first iso- 
lated from the hypothalamus on the basis of its ability to 
inhibit growth hormone secretion by rat anterior pitu- 
itary cells in culture [l]. Subsequently SS-14 has been 
documented to exert antigrowth effects on a variety of 
Synthetic somatostatin-14 was purchased from Pen- 
insula Laboratories, Inc. (Belmont, CA). Dibutyryl-cy- 
clic AMP, 3-isobutyl-1-methyl-xanthine (IBMX), and 
collagenase (type I) were from Sigma Chemical Co. (St. 
Louis, MO). Matrigel and Dispase were obtained from 
Collaborative Research, Inc. (Bedford, MA). 
Hepatocyte Isolation 
I Presented at the Annual Meeting of the Association for Academic 
Surgery, Houston, TX, November 14-17,199O. 
’ This work was supported by NIH Grant 1 R29 DK42485-01. 
Sprague-Dawley male rat (250-275 g) hepatocytes 
were isolated using a two-step collagenase perfusion 
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FIG. 1. Phase-contrast microscopy of rat hepatocytes cultured for 48 hr on Matrigel in presence of IBMX (0.1 mM, 24 hr) (X200). 
technique [17, 181. Briefly, rat liver was perfused for 10 
min with Mg2+/Ca2+ free Hank’s buffer at 37°C followed 
by 8-10 min with Eagle’s minimum essential medium 
(MEM) with 0.05% collagenase (type I). The liver was 
excised and placed in petri dish containing fresh MEM 
with collagenase. The liver capsule was stripped and 
cells were released by gentle manipulation, The result- 
ing crude preparation was filtered through 250 and 100 
pm nylon mesh and collagenase was inactivated with 0.5 
ml of fetal calf serum (FCS). Centrifugal separation was 
employed to minimize contamination by nonparenchy- 
ma1 cells. The cell viability was tested by trypan blue 
exclusion (>90%). The hepatocytes were plated at a cell 
density of lo5 per 16-mm tissue culture dish coated with 
250 ~1 (1:3 v/v) of Matrigel (laminin, heparan sulfate, 
type IV collagen) [19]. When cultured on Matrigel, he- 
patocytes attached rapidly but exhibited minimal 
spreading (Fig. 1) [19], which was different from the 
flattened appearance of hepatocytes cultured on plastic. 
To check the purity of the isolated hepatocytes and to 
exclude a possibility of toxicity by reagents, total protein 
secreted by hepatocytes into the media was measured 
after the method of Bradford, with a Bio-Rad protein 
assay kit. Throughout the 48hr experiment, there was 
no significant difference in protein secretion in presence 
of dibutyryl-CAMP (1 mM), IBMX (0.1 n&f), SS-14 (10 
nM), and known hepatotrophic factors, such as insulin 
(100 rig/ml) or epidermal growth factor (EGF, 100 ng/ 
TABLE 1 
Protein Concentration of Media 
Reagents Protein &g/ml) 
Control 
db-CAMP” (1 mM) 
+ ss-14(10 nhf) 
IBMX (0.1 m&f) 
+ ss-14 
Insulin (100 rig/ml) 
+ ss-14 
EGF (100 rig/ml)* 
+ SS-14b 
66.7 _t 1.5 
72.4 k 10.4 
69.6 31 1.6 
66.3 + 2.2 
70.0 +- 5.5 
64.5 k 6.2 
69.6 + 3.1 
72.0 + 10.6 
66.7 + 1.8 
Note. Freshly isolated hepatocytes were plated as described under 
Materials and Methods. After a 24-hr attachment period, media were 
changed and the appropriate reagents were added. The media were 
collected 24 hr later, and total protein in the media was measured after 
the method of Bradford (BioRad, CA). Data are the mean +- SEM 
from six dishes in two different experiments. 
a Dibutyry-CAMP. 
* Insulin (100 rig/ml) was supplemented. 
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FIG. 2. Immunoblot analysis of secreted albumin into the media 
by rat hepatocytes. The media (25 ~1) from hepatocyte culture dishes 
treated with appropriate reagents were subjected to electrophoresis 
(SDS-PAGE) and immunoblot analysis using anti-rat albumin anti- 
bodies (Organon Teknica Corp.) [ZO, 211. Lane 1, dibutyryl-CAMP (1 
m&4); lane 2, dibutyryl-CAMP + SS-14 (10 nM); lane 3, IBMX (0.1 
mM); lane 4, IBMX + SS-14. 
ml) (Table 1). The presence of secreted albumin in the 
proteins determined above was also demonstrated by an 
immunoblot analysis using anti-rat albumin antibodies 
(Organon Teknica Corp., PA) [20] (Fig. 2). Further, 
[35S]cysteine incorporation into newly secreted albumin 
into the media was not significantly different among 
control, insulin (100 rig/ml), SS-14 (10 nM), and insulin 
+ SS-14 treated hepatocytes [21], thus confirmingviabil- 
ity of hepatocytes treated with SS-14 and/or with other 
reagents. 
Estimation of DNA Synthesis 
DNA synthesis was estimated by the rate of [3H]thy- 
midine incorporation into DNA [22] and by autoradio- 
graphic measurement of the number of labeled nuclei. 
After a 24-hr attachment period, media were changed 
and the appropriate reagents were added. 13H] thymidine 
(-2 &i/dish) was added 6 hr after change of media. 
Using Dispase (a neutral protease produced by Bacillus 
polymyxa) [23] for 2 hr at 37”C, cells were harvested 24 
hr after medium change. Half of the harvested cells were 
processed for counting, and the other half were used to 
determine DNA content. The former half was filtered 
onto GF/C Whatman filters and rinsed with 1 ml of ice- 
cold 15% trichloroacetic acid (TCA, ~2) and with 70% 
ethanol (Xl). Filters were dried and placed in 10 ml of 
scintillation cocktail (EcoLite) and were counted in a 
scintillation counter (Beckman LS 6000LL). A modified 
diphenylamine reaction for desoxypentose was per- 
formed to measure DNA content [24]. [3H]thymidine in- 
corporation was expressed as cpm/pg DNA. 
The labeling index, i.e., the percentage of total nuclei 
labeled with [3H]thymidine, was measured as follows. 
After an 18-hr exposure to [3H]thymidine (2 &i/dish), 
hepatocytes were washed twice with cold phosphate- 
buffered saline and fixed in 4% paraformaldehyde for 10 
min, coated with Kodak NTB-3 emulsion, and exposed 
for 10 days before development in Kodak Dektol. The 
percentage of morphologically defined hepatocytes with 
labeled nuclei was determined by phase contrast micros- 
COPY* 
Cyclic AMP Assay 
Freshly isolated hepatocytes (105/ml) were incubated 
with the appropriate reagents for 5 min. After the incu- 
bation period, the test tubes were placed in an ice-water 
bath for 10 min, then vortexed gently, and centrifuged at 
18OOg for 10 min at 4°C. The pellet was deproteinized 
with 15% TCA, ether extracted, and lyophilized. Cyclic 
AMP levels were measured by competitive protein bind- 
ing assay using an Amersham kit. 
Statistical Analysis 
All values shown represent the mean +- SEM. Wil- 
coxon signed rank test was used for comparing group 
means. The level of significance was established at P 
< 0.05. 
RESULTS 
Effect of Dibutyryl-CAMP on [3Hj Thymidine 
Incorporation 
As shown in Fig. 3, there was dose-dependent stimula- 
tion of [3H]thymidine incorporation by dibutyryl-CAMP 
( 10m7 to 10e3 M). The 1 mM dose was most effective and 
hence used for the remaining experiments. 
Effect of SS-14 on Dibuty&cAMP-Stimulated DNA 
Synthesis 
Addition of dibutyryl-CAMP (1 m&f) resulted in a 
252% increase in [3H]thymidine incorporation com- 
pared to controls. SS-14 (10 nM) significantly inhibited 
this stimulation (Fig. 4). Of the tested doses (0.1 to 10 
nM), 10 nM of SS-14 was most effective. We thus used 
F-k 
,.Ol 
.m -7 -6 -5 -4 -3 
db-CAMP (log M) 
FIG. 3. Dose-dependent stimulation of [3H]thymidine incorpora- 
tion by dibutyryl-CAMP (db-CAMP). Freshly isolated hepatocytes 
were plated as described under Materials and Methods. After a 24-hr 
attachment period, media were changed and dibutyryl-CAMP (10m7 to 
low3 M) was added. [3H]thymidine incorporation into DNA was mea- 
sured after an 18-hr exposure to [3H]thymidine (-2 &i/dish). Points, 
means of six to eight determinations; bars, SEM. 
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Control db-CAMP db-CAMP+ Control IBMX IBMX+ 
(1 mM) ss-14 (O.lmM) s-14 
(IOnM) (1OnM) 
FIG. 4. Effect of SS-14 (10 n&f) on dibutyryl-CAMP (1 
m&f)-stimulated [3H]thymidine incorporation. Methods for deter- 
mining [3H]thymidine incorporation were as for Fig. 2. Columns, 
means from 11-12 dishes from three different experiments; bars, 
SEM. 
FIG. 5. Effect of SS-14 (10 n&f) on IBMX (0.1 n&Q-stimulated 
[3H]thymidine incorporation. Columns, means from 11-12 dishes 
from three different experiments; bars, SEM. 
*P < 0.05 vs control, **P < 0.05 vs IBMX-stimulated [3H]thymi- 
dine incorporation. 
*P < 0.05 vs control, **P < 0.05 vs dibutyryl-CAMP-stimulated 
[3H]thymidine incorporation. 
this dose of SS-14 in this study. Dibutyryl-CAMP also 
increased labeling index of hepatocytes, which was sig- 
nificantly inhibited by SS-14 (Table 2). 
Effects of SS-14 on IBMX-Stimulated DNA Synthesis 
and Intracellular CAMP 
Preliminary experiments showed that 0.1 mM IBMX 
was most effective in stimulation of [3H]thymidine incor- 
poration. IBMX (0.1 mA4)-stimulated [3H]thymidine in- 
corporation and labeling index were inhibited by 10 nM 
SS-14 (Table 2, Fig. 5). To investigate the mechanism of 
this inhibitory effects, we measured the change of intra- 
cellular CAMP of rat hepatocytes. Intracellular CAMP 
TABLE 2 
Effect of 88-14 on Dibutyryl-CAMP (db-cAMP)- 
and IBMX-stimulated Labeling Index 
Reagents Labeling index (%) 
Control 
db-CAMP (1 n&f) 
+ SS-14 (10 nM) 
IBMX (0.1 m&f) 
+ ss-14 
12.3 k 2.4 
35.4 +- 5.6* 
9.1 * 4.4** 
37.5 -c 5.6* 
11.3 + 4.4** 
Note. The labeling index, i.e., the percentage of nuclei with 
13H]thymidine, was measured as described under Materials and Meth- 
ods. Data are the mean t SEM from 7-10 determinations from two 
different experiments. 
* P < 0.01 vs control. 
** P < 0.01 vs db-CAMP- or IBMX-stimulated labeling index. 
was significantly increased by IBMX (0.1 mM) and this 
response was inhibited by 10 nM SS-14 (Fig. 6). 
DISCUSSION 
We have shown that dibutyryl-CAMP (a nonhydrolyz- 
able analog of CAMP) and IBMX (an inhibitor of CAMP 
phosphodiesterase), both of which may increase intra- 
cellular CAMP, stimulate hepatocyte DNA synthesis. 
600, - 
Control IBMX IBMX+ 
(O.lmM) s-14 
(1OnM) 
FIG. 6. Effect of SS-14 (10 n&f) on IBMX (0.1 m&f)-stimulated 
intracellular CAMP accumulation. Conditions for isolation and CAMP 
assay were as described under Materials and Methods. Columns, 
means from six tubes from two different experiments; bars, SEM. 
*P < 0.05 vs control; **P < 0.05 vs IBMX-stimulated CAMP accu- 
mulation. 
KOKUDO ET AL.: INHIBITORY EFFECTS 
Our system is different from previous studies [25-273 
because we did not add any hormones or serum and we 
coated the culture plates with Matrigel. Using only 
CAMP-enhancing agents, we were able to exclude the 
effect of hormones or serum (including unknown fac- 
tors), which may alter the adenylate cyclase activity. 
Thus our system was free from any endocrine stimula- 
tion. And hepatocytes were still functioning in our sys- 
tem as evidenced by the presence of secreted albumin. 
Matrigel is the first complete multicomponent prepara- 
tion of natural solubilized tissue basement membrane. 
This laminin-rich gel is known to support differen- 
tiated functions of cultured hepatocytes for at least 3 
weeks [19]. 
Cyclic AMP is known as one of the intracellular sig- 
nals which initiate hepatocyte proliferation after partial 
hepatectomy [28]. Several lines of evidence obtained in 
studies on cultured hepatocytes [25-271 indicate that 
CAMP acts in the liver as a growth-promoting agent. 
Although there are no well-documented experiments 
showing physiological doses of CAMP, in vitro studies 
using dibutyryl-CAMP have documented that concen- 
trations between 0.1 and 1 mM are effective for stimula- 
tion [25, 29-311. Since our studies showed that dibu- 
tyryl-CAMP was most effective at 1 m&f, we used this 
concentration to stimulate hepatocytes. 
SS-14 (10 r-&f) significantly inhibited DNA synthesis 
of rat hepatocytes stimulated by both dibutyryl-CAMP 
and IBMX. IBMX-stimulated intracellular CAMP accu- 
mulation was inhibited by SS-14, suggesting, in part, 
dependence on adenylate cyclase for antiproliferative 
effect of SS-14. 
By using CAMP analogues, we could bypass signal 
transduction from receptor to the production of CAMP. 
SS-14 is known to inhibit dibutyryl-CAMP-stimulated 
gastric parietal cell activity (aminopyrine uptake) [29]. 
Koch reported that SS-14 inhibited S-Br-CAMP (an- 
other CAMP analogue)-stimulated prolactin release 
from pituitary cells [ 131. In our study, using rat hepato- 
cytes, SS-14 significantly inhibited dibutyryl-CAMP- 
stimulated [3H]thymidine incorporation. The data sug- 
gest that inhibitory actions of SS-14 are both proximal 
and distal to activation of adenylate cyclase. Similar ob- 
servations have recently been reported in the growth 
study using the FRTL5 line of rat thyroid follicular 
cells [32]. 
In conclusion, SS-14 may exert at least part of its an- 
tiproliferative effect via the adenylate cyclase system. 
However, we must investigate the possibility that the 
antiproliferative effect of SS-14 may be mediated via 
multiple pathways because SS-14 has recently been 
shown to inhibit DNA synthesis of thyroid follicular 
cells stimulated by insulin-like growth factor I, which is 
not dependent on CAMP [32]. Further study on other 
signal transduction systems may yield more information 
about mechanisms of hepatocyte growth. 
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